Suppr超能文献

伊维菌素:一种强效的新型抗寄生虫药。

Ivermectin: a potent new antiparasitic agent.

作者信息

Campbell W C, Fisher M H, Stapley E O, Albers-Schönberg G, Jacob T A

出版信息

Science. 1983 Aug 26;221(4613):823-8. doi: 10.1126/science.6308762.

Abstract

Ivermectin is the 22,23-dihydro derivative of avermectin B1, a macrocyclic lactone produced by an actinomycete, Streptomyces avermitilis. It is active at extremely low dosage against a wide variety of nematode and arthropod parasites, apparently by virtue of its action on the mediation of neurotransmission by gamma-aminobutyric acid. It is now in commercial use in various countries for the treatment and control of parasites in cattle, horses, and sheep, and is expected to become available for use in swine and dogs. Since studies with the drug in man are in a preliminary stage, it is not yet known whether ivermectin will be useful in human medicine.

摘要

伊维菌素是阿维菌素B1的22,23 - 二氢衍生物,阿维菌素B1是由放线菌阿维链霉菌产生的一种大环内酯。它在极低剂量下对多种线虫和节肢动物寄生虫具有活性,显然是通过作用于γ-氨基丁酸介导的神经传递发挥作用。目前该药物在各国已用于治疗和控制牛、马和羊身上的寄生虫,预计也将用于猪和狗。由于对该药物在人体上的研究尚处于初步阶段,目前尚不清楚伊维菌素是否对人类医学有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验